173 related articles for article (PubMed ID: 11451585)
1. The contribution of inhibins and activins to malignant prostate disease.
Risbridger GP; Mellor SL; McPherson SJ; Schmitt JF
Mol Cell Endocrinol; 2001 Jun; 180(1-2):149-53. PubMed ID: 11451585
[TBL] [Abstract][Full Text] [Related]
2. The role of inhibins and activins in prostate cancer pathogenesis.
Dowling CR; Risbridger GP
Endocr Relat Cancer; 2000 Dec; 7(4):243-56. PubMed ID: 11174846
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
McPherson SJ; Thomas TZ; Wang H; Gurusinghe CJ; Risbridger GP
J Endocrinol; 1997 Sep; 154(3):535-45. PubMed ID: 9379131
[TBL] [Abstract][Full Text] [Related]
5. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
6. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.
Mellor SL; Cranfield M; Ries R; Pedersen J; Cancilla B; de Kretser D; Groome NP; Mason AJ; Risbridger GP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4851-8. PubMed ID: 11134153
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
8. Regulation of prostate branching morphogenesis by activin A and follistatin.
Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
[TBL] [Abstract][Full Text] [Related]
9. Activins and activin antagonists in the prostate and prostate cancer.
Gold E; Risbridger G
Mol Cell Endocrinol; 2012 Aug; 359(1-2):107-12. PubMed ID: 21787836
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.
Thomas TZ; Wang H; Niclasen P; O'Bryan MK; Evans LW; Groome NP; Pedersen J; Risbridger GP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3851-8. PubMed ID: 9360551
[TBL] [Abstract][Full Text] [Related]
11. Activins in reproductive biology and beyond.
Wijayarathna R; de Kretser DM
Hum Reprod Update; 2016 Apr; 22(3):342-57. PubMed ID: 26884470
[TBL] [Abstract][Full Text] [Related]
12. Role of activins in the male reproductive tract.
Risbridger GP; Cancilla B
Rev Reprod; 2000 May; 5(2):99-104. PubMed ID: 10864854
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
14. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341
[TBL] [Abstract][Full Text] [Related]
15. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
[TBL] [Abstract][Full Text] [Related]
16. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
17. Beta A versus beta B: is it merely a matter of expression?
Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
[TBL] [Abstract][Full Text] [Related]
18. Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures.
Gaddy-Kurten D; Coker JK; Abe E; Jilka RL; Manolagas SC
Endocrinology; 2002 Jan; 143(1):74-83. PubMed ID: 11751595
[TBL] [Abstract][Full Text] [Related]
19. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.
Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R
J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of activin A in stage IV colorectal cancer.
Wildi S; Kleeff J; Maruyama H; Maurer CA; Büchler MW; Korc M
Gut; 2001 Sep; 49(3):409-17. PubMed ID: 11511564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
